Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitomycin C intravesical instillation soon after radical nephroureterectomy for upper urinary tract urothelial carcinoma
jRCTs011180027Completed
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mitomycin c in intrarenal urothelial carcinoma (IUC), ureteral cancer and upper tract urothelial carcinoma (UTUC). Primary endpoint: Bladder recurrence. Started Aug 2016; status: completed.
02
Drugs
mitomycin c
03
Conditions
intrarenal urothelial carcinoma (IUC)ureteral cancerupper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on jRCTs011180027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011180027.